Medical cell technologies for treatment of patients suffering from recessive dystrophic epidermolysis bullosa. Method of intracutaneous administration of fibroblasts

• Main Authors: V. I. Albanova (Author), A. E. Karamova (Author), V. V. Chikin (Author), A. A. Mineyeva (Author)
• Format: Book
• Published: State Scientific Center of Dermatovenereology and Cosmetology, 2017-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Recessive dystrophic epidermolysis bullosa (RDEB) is a severe inherited disease developing due to genetic abnormalities in the synthesis of Type VII collagen by fibroblasts. A low production rate of Type VII collagen and abnormalities related to the formation of anchoring fibrils weaken the epidermi...